ホーム › 自己免疫疾患 › ペンシルベニア › Philadelphia
Philadelphia、PAにおける自己免疫疾患の臨床試験
Philadelphiaとその周辺地域（約30マイル以内）の拠点で、自己免疫疾患に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Autoimmunity After Checkpoint Blockade
被験者募集中観察研究
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
被験者募集中第3相
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
被験者募集中第2/3相
- Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
被験者募集中第2相
- Fox Chase Cancer Center- Temple BMT, Philadelphia
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
被験者募集中第3相
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
被験者募集中第3相
- GSK Investigational Site, Philadelphia
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
被験者募集中第1/2相
- Children's Hospital of Philadelphia, Philadelphia
Abatacept for the Treatment of Giant Cell Arteritis
被験者募集中第3相
- University of Pennsylvania, Philadelphia
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
被験者募集中第3相
- The Children's Hospital of Philadelphia, Philadelphia
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
被験者募集中第2/3相
- Thomas Jefferson University Hospital, Philadelphia
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
被験者募集中観察研究
- Children's Hospital of Philadelphia, Philadelphia
- Nemours - Alfred I. duPont Hospital for Children, Brandywine · 21マイル先
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
被験者募集中第1/2相
- University of Pennsylvania, Philadelphia
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
被験者募集中第1相
- Jefferson Einstein Hospital Philadelphia, Philadelphia
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
被験者募集中第1相
- Temple University Hospital, Philadelphia
Central Vein Sign in Multiple Sclerosis Extension Study
被験者募集中
- University of Pennsylvania, Philadelphia
X-linked Moesin Associated Immunodeficiency
被験者募集中観察研究
- Perelman School of medecine, Philadelphia
他の都市における自己免疫疾患の試験
- Houston, TX21件の研究
- Washington, DC19件の研究
- New York City, NY19件の研究
- Durham, NC15件の研究
- Boston, MA13件の研究
- Chicago, IL12件の研究
- Los Angeles, CA12件の研究
- Dallas, TX9件の研究
- Atlanta, GA8件の研究
- Portland, OR8件の研究
- Milwaukee, WI8件の研究
- Cleveland, OH8件の研究
Philadelphiaにおける他の研究
- がん（全種類）59件の研究
- 乳がん56件の研究
- 非小細胞肺癌51件の研究
- 転移性癌46件の研究
- 前立腺がん44件の研究
- 大腸癌44件の研究
- 卵巣がん44件の研究
- 肺がん36件の研究
- 急性骨髄性白血病34件の研究
- 心不全31件の研究
- 子宮内膜がん28件の研究
- うつ病26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。